VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K902. A total of 13 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,723,000 | +4.7% | 329,600 | +26.4% | 0.23% | -24.3% |
| Q2 2017 | $4,512,000 | +67.0% | 260,800 | +6.4% | 0.30% | +31.6% |
| Q1 2017 | $2,702,000 | +271.7% | 245,000 | +389.0% | 0.23% | +570.6% |
| Q4 2016 | $727,000 | -41.1% | 50,100 | -0.4% | 0.03% | -40.4% |
| Q3 2016 | $1,235,000 | +14.9% | 50,300 | -5.8% | 0.06% | +5.6% |
| Q2 2016 | $1,075,000 | +70.9% | 53,400 | +123.4% | 0.05% | +28.6% |
| Q1 2016 | $629,000 | – | 23,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 350,400 | $62,504,000 | 0.86% |
| EcoR1 Capital, LLC | 1,265 | $1,347,000 | 0.61% |
| SIMPLEX TRADING, LLC | 995 | $1,062,000 | 0.08% |
| Timber Hill LLC | 92,600 | $16,518,000 | 0.07% |
| Citadel Advisors | 329,400 | $58,758,000 | 0.06% |
| JPMORGAN CHASE & CO | 288,800 | $51,516,000 | 0.01% |
| Catalyst Capital Advisors LLC | 5 | $10,000 | 0.00% |